跳至主要内容
临床试验/NL-OMON44083
NL-OMON44083已完成4 期

A prospective Randomized Controlled Trial to Evaluate the Primary Prevention of sudden cardiac death using implantable cardioverter defibrillators in dialysis patients. - Implantable cardioverter device in dialysis patients. ICD2 study

eids Universitair Medisch Centrum0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Patients 55 to 80 years of age
  • -End Stage Renal Disease (ESRD)
  • -> 90 days after start dialysis
  • -Not eligible for kidney transplantation or kidney transplantation not expected within 3 years after inclusion;zie protocol p 21

排除标准

  • -Terminal congestive heart failure according NYHA class 4 at time of randomization
  • -Non arrhythmic medical condition making 1-year survival unlikely
  • -Excessive perioperative risk for ICD implantation
  • -HIV infection
  • -Patients with central venous line
  • -Acute Myocardial Infarction (AMI) last 40 days
  • -ICD indication according current guidelines
  • -SCD survivors
  • -(non) ischemic cardiomyopathy with LVEF<30%Not able to sign informed consent
  • -Expected poor compliance with protocol
  • -Inclusion in other study protocols

研究者

相似试验

A prospective Randomized Controlled Trial to... | 临床试验